Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant.
The pharmacokinetics of amikacin administered intravenously at currently recommended doses (7.5 mg/kg every 12 h for infants with less than 7 days of life; 7.5 mg/kg every 8 h for infants with greater than 7 days of life) were studied in 28 preterm infants weighing less than 2,500 g (mean +/- standa...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1990
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171570/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2327775/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.2.265 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
